The article from Nature, presents a study on the relationship between endoscopic healing (EH) and the effectiveness of biologic treatments…
Browsing: Clinical Updates
In patients with inflammatory bowel disease, neither biologics nor small molecule targeted therapies increase the risk for major adverse cardiac…
The article on Healio discusses the new clinical guideline published by the American College of Gastroenterology (ACG) in the American…
Patients with inflammatory bowel disease are at increased risk for respiratory syncytial virus infection, according to new research presented at…
HCP Live covers significant developments in the field of gastroenterology during December 2023. Key highlights include: American Gastroenterological Association (AGA)…
In patients with inflammatory bowel disease, neither biologics nor small molecule targeted therapies increase the risk for major adverse cardiac…
The article from Cureus focuses on the advancements in early cancer detection, exploring the roles of biomarkers, circulating DNA (ctDNA),…
A study from the Perelman School of Medicine at the University of Pennsylvania found that liver cancer screening rates among…
Patients with cirrhosis are especially susceptible to liver cancer, but mailing screening orders directly to patients helped nudge them toward…
The Fierce Healthcare article discusses the outlook for 2024 regarding the use of GLP-1 medications, particularly in the context of…